Key Financial Data Of Group

Chiome Bioscience Inc. - Filing #7550870

Concept As at
2023-06-30
2023-01-01 to
2023-06-30
2023-04-01 to
2023-06-30
2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2022-06-30
2022-04-01 to
2022-06-30
2022-01-01 to
2022-06-30
Key financial data of group
Business results of group
Net sales
358,889,000 JPY
630,815,000 JPY
278,211,000 JPY
Ordinary profit (loss)
-662,139,000 JPY
-1,243,838,000 JPY
-768,686,000 JPY
Net assets
1,144,629,000 JPY
1,790,746,000 JPY
1,476,135,000 JPY
Total assets
1,685,551,000 JPY
2,215,470,000 JPY
1,920,212,000 JPY
Basic earnings (loss) per share
-13.70
-9.00
-28.26
-6.53
-18.17
Diluted earnings per share
Equity-to-asset ratio
0.672 xbrli:pure
0.802 xbrli:pure
0.753 xbrli:pure
Net cash provided by (used in) operating activities
-595,281,000 JPY
-1,191,009,000 JPY
-660,225,000 JPY
Net cash provided by (used in) investing activities
82,000 JPY
JPY
JPY
Net cash provided by (used in) financing activities
113,359,000 JPY
1,127,291,000 JPY
341,172,000 JPY
Cash and cash equivalents
1,245,431,000 JPY
1,727,270,000 JPY
1,471,935,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.